Study Evaluating the Effects of Avanafil on Semen Parameters

NCT01768676 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 181

Last updated 2015-12-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether avanafil will affect different aspects of sperm production.

Conditions

Interventions

DRUG

avanafil

100 mg

DRUG

Placebo

Sponsors & Collaborators

  • VIVUS LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01768676 on ClinicalTrials.gov